Clinical Trial Update: ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Medisorb Naltrexone (VIVITROL) for adults with opioid dependence has completed. Results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Opiate Dependence | Phase 3 | Status: COMPLETED | Results posted: 2011-01-21